Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Revvity's inventories, raw materials & components for the quarter that ended in Mar. 2026 was MXN3,062 Mil.
Revvity's quarterly raw materials
declined
from Sep. 2025 (MXN3,204 Mil) to Dec. 2025 (MXN3,116 Mil) and
declined
from Dec. 2025 (MXN3,116 Mil) to Mar. 2026 (MXN3,062 Mil).
Revvity's annual raw materials
increased
from Dec. 2023 (MXN3,348 Mil) to Dec. 2024 (MXN3,639 Mil) but then
declined
from Dec. 2024 (MXN3,639 Mil) to Dec. 2025 (MXN3,116 Mil).
Revvity Inventories, Raw Materials & Components Historical Data
* Premium members only.
The historical data trend for Revvity's Inventories, Raw Materials & Components can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revvity Inventories, Raw Materials & Components Chart
What does a Inventories, Raw Materials & Components of MXN3,062 Mil mean?
Revvity (MEX:PKI) has a Inventories, Raw Materials & Components of MXN3,062 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Revvity and its competitors.
Is Revvity's Inventories, Raw Materials & Components too high?
Revvity's current Inventories, Raw Materials & Components is MXN3,062 Mil. Overall, Revvity has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revvity's Inventories, Raw Materials & Components compare to ICLR and CRL?
Revvity's Inventories, Raw Materials & Components of MXN3,062 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Diagnostics & Research company?
A good Inventories, Raw Materials & Components depends on the Medical Diagnostics & Research industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Revvity and its competitors. Revvity's current Inventories, Raw Materials & Components is MXN3,062 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Based on GuruFocus' analysis, Revvity (MEX:PKI) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN2,130.92, compared to a current price of MXN1,910.00 — trading 10.4% below its estimated fair value. The current Inventories, Raw Materials & Components is MXN3,062 Mil. Revvity's overall GF Score™ is 60/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Revvity (MEX:PKI), the current Inventories, Raw Materials & Components is MXN3,062 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revvity (MEX:PKI) Overvalued in 2026?
Based on GuruFocus' analysis, Revvity stock appears to be undervalued.
The current stock price of MXN1,910.00 is trading 10.4% below its estimated GF Value™ of MXN2,130.92.
GuruFocus considers Revvity to be Modestly Undervalued.
Key valuation signals for MEX:PKI:
Inventories, Raw Materials & Components: MXN3,062 Mil
GF Value™: MXN2,130.92 vs. price of MXN1,910.00 (10.4% below fair value)
No single metric tells the full story. See the MEX:PKI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
60GF Score
Get the complete analysis for MEX:PKI
Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PKI has been successfully added to your 
